Skip to content

COVID-19 VACCINE

We are researching for a new vaccine against COVID-19 (SARS-CoV-2)

COVID-19 VACCINE based on recombinant protein

HIPRA SARS-CoV-2 is a recombinant protein vaccine designed to optimize its safety and induce a potent immune response that neutralizes the COVID-19 virus.

COVID-19 comprehensive diagnostic service

Discover the clinical analysis service for the diagnosis of COVID-19 for health centers, occupational risk prevention services and companies. Delivery of results in less than 24 hours from the reception of the sample to our laboratory.

HIPRA’s responsibility to society

Since the start of the health crisis caused by the COVID-19, we contacted the public healthcare authorities and placed at their disposal our new diagnostic laboratory and part of our technical staff.

WHAT WE ARE DOING

HIPRA’s responsibility to society

Since the start of the health crisis caused by the COVID-19, we contacted the public healthcare authorities and placed at their disposal our new diagnostic laboratory and part of our technical staff.

KNOWLEDGE:

Our Knowledge in Diagnosing COVID-19

Learn about the main diagnostic techniques available to tackle the COVID-19 pandemic.

OUR EXPERIENCE:

HIPRA, a reference in research

We are a pharmaceutical multinational company dedicated to the research, production and marketing of vaccines and diagnostic products. We have over 60 years of market experience and 38 global subsidiaries worldwide.

For more information, contact us

Request a phone call or a commercial visit to learn about our prevention service

Contact us and we will detail our service of extraction, shipment, analysis of samples and results

Basic Personal Data Protection information:

Controller: LABORATORIOS HIPRA, S.A.
Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate interest.
Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

Solidly established company on an international scale:

We have our own subsidiaries in 39 countries and a distribution network that enables our products and services to reach customers in more than 100 countries